Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Verna L, Welch"'
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-11 (2024)
Abstract Amidst the backdrop of the COVID-19 pandemic, vaccine innovation has garnered significant attention, but this field was already on the cusp of a groundbreaking renaissance. Propelling these advancements are scientific and technological break
Externí odkaz:
https://doaj.org/article/eacbe4bd9ef24999867befe83e687ce4
Publikováno v:
Healthcare, Vol 12, Iss 16, p 1591 (2024)
Influenza and influenza-like illness (ILI) pose significant clinical and economic burdens globally each year. This systematic literature review examined quantitative studies evaluating the impact of patients’ influenza/ILI on their caregivers’ we
Externí odkaz:
https://doaj.org/article/7b9a1d869a80480c87201c5197b5f0c1
Autor:
Leah J. McGrath, Mary M. Moran, Tamuno Alfred, Maya Reimbaeva, Manuela Di Fusco, Farid Khan, Verna L. Welch, Deepa Malhotra, Alejandro Cane, Santiago M. C. Lopez
Publikováno v:
Frontiers in Pediatrics, Vol 11 (2023)
IntroductionWe compared hospitalization outcomes of young children hospitalized with COVID-19 to those hospitalized with influenza in the United States.MethodsPatients aged 0-
Externí odkaz:
https://doaj.org/article/aa559cc258c64e8d91044e939e5e75a2
Autor:
Verna L. Welch, Tom Metcalf, Richard Macey, Kristen Markus, Amy J. Sears, Ashley Enstone, Jakob Langer, Amit Srivastava, Alejandro Cane, Timothy L. Wiemken
Publikováno v:
Vaccines, Vol 11, Iss 1, p 180 (2023)
Influenza is a common respiratory infection associated with a substantial clinical, humanistic, and economic burden globally. Vaccines are essential to prevent and control influenza and are recommended by public-health agencies, such as the WHO and U
Externí odkaz:
https://doaj.org/article/7ca60750192b4078bc17766dcba0f261
Autor:
Jakob Langer, Verna L. Welch, Mary M. Moran, Alejandro Cane, Santiago M. C. Lopez, Amit Srivastava, Ashley L. Enstone, Amy Sears, Kristen J. Markus, Maria Heuser, Rachel M. Kewley, Isabelle J. Whittle
Publikováno v:
Advances in Therapy. 40:1601-1627
Autor:
Elihu H. Estey, Garrett A Hartley, Mary-Elizabeth M. Percival, Paul C. Hendrie, Roland B. Walter, Nicholas P Howard, Verna L Welch, Megan Othus, Anna B. Halpern
Publikováno v:
Leukemia & Lymphoma. 63:142-151
We recently reported an early hospital discharge (EHD) care strategy following intensive acute myeloid leukemia (AML)-like chemotherapy is safe. To evaluate its impact on infectious outcomes, we compared all adults treated from 8/1/2014 to 7/31/2018
Autor:
Garrett A Hartley, Mary-Elizabeth M. Percival, Anna B. Halpern, Elihu H. Estey, Paul C. Hendrie, Roland B. Walter, Nicholas P Howard, Verna L Welch, Linyi Tang, Megan Othus, Nathan J Moore, Kyle E Bastys
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:27-36
Background: Early hospital discharge (EHD) after intensive acute myeloid leukemia (AML) induction chemotherapy has become routine at the University of Washington/Seattle Cancer Care Alliance over the past several years. We assessed the financial impl
Autor:
Carla Mamolo, Joseph C. Cappelleri, Michele Wilson, Verna L Welch, Matthew Cawson, James Brockbank, Christopher Knight, Roland B. Walter
Publikováno v:
Pharmacoeconomics
Background Gemtuzumab ozogamicin (GO) was approved in 2017 in the US for the treatment of adults with newly diagnosed CD33-positive (CD33+) acute myeloid leukemia (AML), and adults and pediatric patients with CD33+ relapsed/refractory (R/R) AML. Obje
Autor:
Paul C. Hendrie, Garrett A Hartley, Roland B. Walter, Elihu H. Estey, Sioban Keel, Nicholas P Howard, Ryan D. Cassaday, Johnnie J. Orozco, Andrei R. Shustov, Nikita V Baclig, Anna B. Halpern, Terry Gernsheimer, Bart L. Scott, Vivian G. Oehler, Mary-Elizabeth M. Percival, Pamela S. Becker, Verna L Welch, Megan Othus, Sarah A. Buckley
Publikováno v:
Leukemia. 34:635-639
Autor:
Anna B, Halpern, Megan, Othus, Nicholas P, Howard, Paul C, Hendrie, Mary-Elizabeth M, Percival, Garrett A, Hartley, Verna L, Welch, Elihu H, Estey, Roland B, Walter
Publikováno v:
Leukemialymphoma. 63(1)
We recently reported an early hospital discharge (EHD) care strategy following intensive acute myeloid leukemia (AML)-like chemotherapy is safe. To evaluate its impact on infectious outcomes, we compared all adults treated from 8/1/2014 to 7/31/2018